S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q3 2020

Avoro Capital Advisors

Period: Q3 2020 Β· Filed: 2020-11-16
View on SEC EDGAR β†—
AUM
$7.04B
Total portfolio value
Positions
46
Reported securities
Top Holding
IMMU
31.7% $2.23B
QoQ Changes
+8 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2020-11-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
IMMUIMMUNOMEDICS INC$2.23B31.71%β€”β€”
31.7%
MRTXMIRATI THERAPEUTICS INC$721.2M10.25%β€”β€”
10.3%
HZNPHORIZON THERAPEUTICS PLC$594.3M8.44%β€”β€”
8.4%
IOVAIOVANCE BIOTHERAPEUTICS INC$313.9M4.46%$32.92$4.31-86.9%
4.5%
ASNDASCENDIS PHARMA$277.8M3.95%$154.32$274.50+77.9%
4.0%
MYOKMYOKARDIA INC$257.0M3.65%β€”β€”
3.6%
ARGXARGENX SE$236.9M3.37%$262.52$939.68+257.9%
3.4%
SRPTSAREPTA THERAPEUTICS INC$235.2M3.34%$140.43$19.28-86.3%
3.3%
ARNAARENA PHARMACEUTICALS INC$231.8M3.29%β€”β€”
3.3%
FOLDAMICUS THERAPEUTICS INC$153.2M2.18%β€”β€”
2.2%
XLRNACCELERON PHARMA INC$151.9M2.16%β€”β€”
2.2%
BMRNBIOMARIN PHARMACEUTICAL INC$133.1M1.89%$76.08$58.99-22.5%
1.9%
MRSNMERSANA THERAPEUTICS INC$126.6M1.80%β€”β€”
1.8%
MDGLMADRIGAL PHARMACEUTICALS INC$105.7M1.50%$118.73$528.10+344.8%
1.5%
DCPHDECIPHERA PHARMACEUTICALS INC$93.4M1.33%β€”β€”
1.3%
ADAPYADAPTIMMUNE THERAPEUTICS PLC$87.8M1.25%$7.98$0.04-99.5%
1.3%
KPTIXXXXKARYOPHARM THERAPEUTICS INC$87.6M1.24%β€”β€”
1.2%
CNSTCONSTELLATION PHARMACEUTICALS INC$86.6M1.23%β€”β€”
1.2%
ADVMADVERUM BIOTECHNOLOGIES INC$82.4M1.17%β€”β€”
1.2%
TRILLIUM THERAPEUTICS INC$78.2M1.11%β€”β€”
1.1%
KURAKURA ONCOLOGY INC$74.6M1.06%$30.64$11.10-63.8%
1.1%
CBAYCYMABAY THERAPEUTICS INC$74.6M1.06%β€”β€”
1.1%
QUREUNIQURE NV$64.5M0.92%$36.83$41.81+13.5%
0.9%
PMVPPMV PHARMACEUTICALS INC$57.6M0.82%$35.50$1.22-96.6%
0.8%
RLMDRELMADA THERAPEUTICS INC$56.4M0.80%$37.62$6.28-83.3%
0.8%
ISEEIVERIC BIO INC$40.9M0.58%β€”β€”
0.6%
ATNXATHENEX INC$39.5M0.56%β€”β€”
0.6%
MRNSMARINUS PHARMACEUTICALS INC$38.5M0.55%β€”β€”
0.6%
XENEXENON PHARMACEUTICALS INC$31.0M0.44%$11.07$60.96+450.7%
0.4%
CUECUE BIOPHARMA INC$28.1M0.40%$451.50$28.26-93.7%
0.4%

Quarter-on-Quarter Activity

Q3 2020 vs. Q2 2020

New Positions (8)

TickerIssuerNotionalSince Filing
PMVPPMV PHARMACEUTICALS INC$57.6M-96.6%
ALTALTIMMUNE INC$26.4M
RLAYRELAY THERAPEUTICS INC$21.3M
RAPTRAPT THERAPEUTICS INC$18.5M
RACATHERAPEUTICS ACQUISITION CORP$14.4M
GNCAGENOCEA BIOSCIENCES INC$11.6M
ITOSITEOS THERAPEUTICS INC$11.3M
BCTGBCTG ACQUISITION CORP$8.7M

Exited Positions (7)

TickerIssuerNotional
ALLOALLOGENE THERAPEUTICS INC$48.3M
AUPHAURINIA PHARMACEUTICALS INC$27.1M
TCDAQTRICIDA INC$16.5M
PTCTPTC THERAPEUTICS INC$16.5M
RVMDREVOLUTION MEDICINES INC$9.6M
BDSIBIODELIVERY SCIENCES INTL$8.9M
CRDFCARDIFF ONCOLOGY INC$5.0M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
ADAPYADAPTIMMUNE THERAPEUTICS PLC$87.7M+5400.0%-99.5%
ARNAARENA PHARMACEUTICALS INC$172.1M+226.3%
AMRNXXXXAMARIN CORP PLC$11.4M+200.0%
MDGLMADRIGAL PHARMACEUTICALS INC$66.0M+154.3%+344.8%
KURAKURA ONCOLOGY INC$57.5M+131.9%-63.8%
CBAYCYMABAY THERAPEUTICS INC$56.3M+96.2%
XLRNACCELERON PHARMA INC$52.8M+29.8%
HZNPHORIZON THERAPEUTICS PLC$260.8M+27.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
MRNSMARINUS PHARMACEUTICALS INC$8.2M-74.9%
ZGNXZOGENIX INC$-45.1M-61.1%
ATNXATHENEX INC$-13.5M-15.2%
KPTIXXXXKARYOPHARM THERAPEUTICS INC$-45.0M-14.3%
IOVAIOVANCE BIOTHERAPEUTICS INC$29.5M-8.0%-86.9%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$-15.7M-8.0%
ARGXARGENX SE$18.4M-7.0%+257.9%
RNAMAVIDITY BIOSCIENCES INC$-1.2M-6.8%
← Back to Hedge Funds